Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore S
Vaccines (Basel). 2024; 12(10).
PMID: 39460301
PMC: 11512284.
DOI: 10.3390/vaccines12101134.
Mennini M, Piccirillo M, Furio S, Valitutti F, Ferretti A, Strisciuglio C
Front Allergy. 2024; 5:1473352.
PMID: 39450374
PMC: 11499231.
DOI: 10.3389/falgy.2024.1473352.
Petrovsky N
Int J Mol Sci. 2024; 25(17).
PMID: 39273405
PMC: 11395249.
DOI: 10.3390/ijms25179459.
Goetz M, Thotathil N, Zhao Z, Mitragotri S
Bioeng Transl Med. 2024; 9(4):e10663.
PMID: 39036089
PMC: 11256182.
DOI: 10.1002/btm2.10663.
Hoang-Phou S, Pal S, Slepenkin A, Abisoye-Ogunniyun A, Zhang Y, Gilmore S
bioRxiv. 2024; .
PMID: 38895407
PMC: 11185655.
DOI: 10.1101/2024.06.04.597210.
Recombinant mycobacterial DNA-binding protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vaccinated individuals' blood cells in combination with CpG-DNA.
Ozeki Y, Yokoyama A, Nishiyama A, Yoshida Y, Ohara Y, Mashima T
Sci Rep. 2024; 14(1):9141.
PMID: 38644371
PMC: 11033290.
DOI: 10.1038/s41598-024-58836-8.
Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems.
White C, Glover M, Gandhapudi S, Richards K, Sant A
Vaccines (Basel). 2024; 12(3).
PMID: 38543915
PMC: 10975948.
DOI: 10.3390/vaccines12030281.
The Host Response to Coccidioidomycosis.
Kirkland T, Hung C, Shubitz L, Beyhan S, Fierer J
J Fungi (Basel). 2024; 10(3).
PMID: 38535182
PMC: 10971205.
DOI: 10.3390/jof10030173.
Monitoring Memory B Cells by Next-Generation ImmunoSpot Provides Insights into Humoral Immunity that Measurements of Circulating Antibodies Do Not Reveal.
Lehmann P, Liu Z, Becza N, Valente A, Wang J, Kirchenbaum G
Methods Mol Biol. 2024; 2768:167-200.
PMID: 38502394
DOI: 10.1007/978-1-0716-3690-9_11.
Immune Potentiation of PLGA Controlled-Release Vaccines for Improved Immunological Outcomes.
Cassaidy B, Moser B, Solanki A, Chen Q, Shen J, Gotsis K
ACS Omega. 2024; 9(10):11608-11614.
PMID: 38496947
PMC: 10938429.
DOI: 10.1021/acsomega.3c06552.
Complete Freund's adjuvant as a confounding factor in multiple sclerosis research.
Lazarevic M, Stanisavljevic S, Nikolovski N, Dimitrijevic M, Miljkovic D
Front Immunol. 2024; 15:1353865.
PMID: 38426111
PMC: 10902151.
DOI: 10.3389/fimmu.2024.1353865.
Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia.
Kawahara E, Shibata T, Hirai T, Yoshioka Y
Front Immunol. 2024; 14:1282016.
PMID: 38169867
PMC: 10758452.
DOI: 10.3389/fimmu.2023.1282016.
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.
Roe J, Seely K, Bussard C, Eischen Martin E, Mouw E, Bayles K
Pharmaceutics. 2023; 15(7).
PMID: 37514190
PMC: 10384176.
DOI: 10.3390/pharmaceutics15072004.
Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods.
Lin K, Cao H, Luan N, Wang Y, Hu J, Liu C
Vaccines (Basel). 2023; 11(5).
PMID: 37243107
PMC: 10223669.
DOI: 10.3390/vaccines11051003.
Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants.
Walters A, Ali A, Wang J, Al-Jamal K
Drug Deliv Transl Res. 2022; 13(7):2032-2040.
PMID: 36417163
PMC: 10238356.
DOI: 10.1007/s13346-022-01258-8.
Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes.
Duhen T, Gough M, Leidner R, Stanton S
Front Oral Health. 2022; 3:902160.
PMID: 35937775
PMC: 9354490.
DOI: 10.3389/froh.2022.902160.
Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids.
Maldonado E, Morales-Pison S, Urbina F, Solari A
Vaccines (Basel). 2022; 10(4).
PMID: 35455336
PMC: 9028413.
DOI: 10.3390/vaccines10040587.
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Tabarsi P, Anjidani N, Shahpari R, Mardani M, Sabzvari A, Yazdani B
Clin Microbiol Infect. 2022; 28(9):1263-1271.
PMID: 35436611
PMC: 9012510.
DOI: 10.1016/j.cmi.2022.04.004.
Liposome-polymer complex for drug delivery system and vaccine stabilization.
Sriwidodo , Umar A, Wathoni N, Zothantluanga J, Das S, Luckanagul J
Heliyon. 2022; 8(2):e08934.
PMID: 35243059
PMC: 8861389.
DOI: 10.1016/j.heliyon.2022.e08934.
Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice.
Khan M, Malik A, Alzohairy M, Alruwetei A, Alhatlani B, Al Rugaie O
Molecules. 2022; 27(2).
PMID: 35056718
PMC: 8778403.
DOI: 10.3390/molecules27020403.